Relapsing-remitting multiple sclerosis patients' experience with natalizumab a phenomenological investigation

International Journal of MS Care

Volumn 14, Issue 1, 2012, Pages 39-44

  Miller, Colleen E ^a,c   Karpinski, Mary ^a   Jezewski, Mary Ann ^b  

^a JACOBS NEUROLOGICAL INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867284792     PISSN: 15372073     EISSN: None     Source Type: Journal    
DOI: 10.7224/1537-2073-14.1.39     Document Type: Article

References (14)

1. World Health Organization. Programme on mental health. WHOQOL: measuring quality of life. http://www.who.int/mental_health/media/68.pdf. Published 1997. Accessed August 26, 2009.
2. Stroud NM, Minahan CC. The impact of regular physical activity on fatigue, depression, and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes. 2009;7:68.
3. Phillips LH, Saldias A, McCarrey A, et al. Attentional lapses, emotional regulation and quality of life in multiple sclerosis. Br J Clin Psychol. 2009;48:101-106.
4. Rudick RA, Miller D, Hass S, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol. 2007;62:335-346.
5. Miller CM. The lived experience of relapsing multiple sclerosis: a phenomenological study. J Neurosci Nurs. 1997;29:294-304.
6. Miller C, Jezewski M. A phenomenological assessment of relapsing MS patients' experiences during treatment with interferon beta-1a. J Neurosci Nurs. 2001;33:240-244.
7. Miller C, Jezewski M. Relapsing MS patients' experiences with glatiramer acetate treatment: a phenomenological study. J Neurosci Nurs. 2006;38:37-41.
8. Cohen MZ. A historical overview of the phenomenological movement. Image. 1987;19:31-34.
9. Heidegger M. Being and Time. Macqarre J, Robinson E, trans. 1962. New York, NY: Harper and Row; 1962.
10. Kockelmans JJ. Heidegger's " Being and Time" : The Analytic of Dasein as Fundamental Ontology. Washington, DC: Center for Advanced Research in Phenomenology, University Press of America; 1989.
11. Colaizzi P. Psychological research as the phenomenologist views it. In: Vale RS, King M, eds. Existential Phenomenological Alternatives for Psychology. Oxford: Oxford University Press; 1978:48-71.
12. Mishel MH. Uncertainty in chronic illness. Annu Rev Nurs Res.1999;17:269-294.
13. Charmaz K. Good Days, Bad Days: The Self in Chronic Illness and Time. New York, NY: McGraw Hill; 1991.
14. Miller CE, Umhauer MA. Emerging oral therapies for multiple sclerosis. J Neurosci Nurs. 2011;43:3-14.